S 05985 combination versus AT1-Receptor Blocker/thiazide: a comparison of blood pressure lowering - efficacy and safety

Phase 3

Completed

• Conditions: Essential arterial hypertension; Circulatory System; Hypertension

• Registration Number: ISRCTN61335805
• Lead Sponsor: Institut de Recherches Internationales Servier (France)

Brief Summary

2015 results in poster in http://journals.lww.com/jhypertension/Abstract/2015/06001/PP_07_17___A_RANDOMIZED,_DOUBLE_BLIND_STUDY_OF_THE.580.aspx`

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-02-29
• Study Completion: 2009-12-31
• Last Update Posted: 21 May 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

1. Men or women
2. Over 18 years
3. Essential arterial hypertension

Exclusion Criteria

1. Pregnancy, breast-feeding, childbearing potential without medically accepted method of contraception
2. Acute or chronic illness
3. Secondary hypertension
4. Malignant hypertension
5. Clinical symptomatic hypotension

Study & Design

• Study Type: Interventional
• Study Design: Not specified